RecruitingNCT06503640
Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)
Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease
Sponsor
China-Japan Friendship Hospital
Enrollment
100 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to explore the incidence and effect on prognosis of coronary microvascular dysfunction in patients present of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) \>0.80.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- presence of stable anginal symptoms, a clinical indication for invasive coronary angiography, and no hemodynamically significant epicardial coronary artery disease, defined as fractional flow reserve (FFR) >0.80
Exclusion Criteria5
- acute myocardial infarction
- significant valvular heart disease
- advanced chronic kidney disease
- patients with significant epicardial coronary artery stenosis (>70% in major vessels by diagnostic coronary angiography) needing percutaneous coronary intervention
- patients unable to provide written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06503640
Related Trials
Coronary Flow During Rapid Heart Rates
NCT058411991 location
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
NCT070935281 location
Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)
NCT069913222 locations
Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
NCT066001781 location
Improving Coronary Vascular Health in Women
NCT068439021 location